Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. DrugBank Drug (Description in trials) KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1 Alnuctamab
(An asymmetric immunoglobulin G1 x CD3 T-cell bispecific monoclonal antibody)		[1] Alnuctamab---[1] 49 💬
2 ARGX-119
(a fully humanized immunoglobulin gamma 1 that specifically targets and activates MuSK)		[1] ARGX-119---[3] 2, 3, 12 💬
3 Human immunoglobulin G
(Immunoglobulin G)		[7] Human Immunoglobulin; Human Immunoglobulin G; HUMAN NORMAL IMMUNOGLOBULIN; Immune globulin; Immunoglobulin; IMMUNOGLOBULIN G; Intravenous immunoglobulin[1] Globulin, immune 💬 --[4] 14, 50, 63, 65 💬
4 OMS906
(Humanized immunoglobulin G4 monoclonal antibody directed against mannan-binding lectin-associated serine protease-3)		[1] OMS906---[2] 62, 223 💬
5 Talquetamab
(IMMUNOGLOBULIN G4)		[1] Talquetamab[1] Talquetamab 💬 [1] CD3E 💬 [11] Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬[2] 11, 28 💬
6 Telitacicept
(FUSION PROTEIN WITH HUMAN IMMUNOGLOBULIN G1)		[1] Telitacicept---[14] 11, 13, 14, 46, 48, 49, 51, 53, 63, 66, 162, 222, 223, 300 💬